The newly revised Diabetes ABFM-developed KSA activity focuses on preventing and diagnosing diabetes mellitus, recognizing the clinical implications of insulin-resistance syndromes, recognizing, and managing microvascular complications of diabetes mellitus, managing diabetic ketoacidosis and non-ketotic hyperosmolar coma, nonpharmacologic management of diabetes mellitus, and pharmacologic management of diabetes mellitus.